Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Immunologic Phenotyping: The Future of Personalized MG Care
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Exploring Genetic Links Between EBV Clearance and MS Risk
Navigating Emerging Treatment Options in MG
The New Era of Targeted Therapy for Myasthenia Gravis
Uncovering TK2d: How to Navigate Diagnostic Challenges
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Outcome Measures Capture Progression in Late-Onset TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.